These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 22189999)
1. Characterisation of adiponectin multimers and the IGF axis in humans with a heterozygote mutation in the tyrosine kinase domain of the insulin receptor gene. Højlund K; Beck-Nielsen H; Flyvbjerg A; Frystyk J Eur J Endocrinol; 2012 Mar; 166(3):511-9. PubMed ID: 22189999 [TBL] [Abstract][Full Text] [Related]
2. Elevated free IGF2 levels in localized, early-stage breast cancer in women. Espelund U; Cold S; Frystyk J; Ørskov H; Flyvbjerg A Eur J Endocrinol; 2008 Nov; 159(5):595-601. PubMed ID: 18719053 [TBL] [Abstract][Full Text] [Related]
3. Partial rescue of in vivo insulin signalling in skeletal muscle by impaired insulin clearance in heterozygous carriers of a mutation in the insulin receptor gene. Højlund K; Wojtaszewski JF; Birk J; Hansen BF; Vestergaard H; Beck-Nielsen H Diabetologia; 2006 Aug; 49(8):1827-37. PubMed ID: 16761106 [TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor 2 (IGF2 ) and IGF-binding protein 1 (IGFBP1) gene variants are associated with overfeeding-induced metabolic changes. Ukkola O; Sun G; Bouchard C Diabetologia; 2001 Dec; 44(12):2231-6. PubMed ID: 11793026 [TBL] [Abstract][Full Text] [Related]
5. Analysis of IGF and IGFBP as prognostic serum biomarkers for adrenocortical carcinoma. Patel D; Ellis R; Howard B; Boufraqech M; Gara SK; Zhang L; Quezado MM; Nilubol N; Kebebew E Ann Surg Oncol; 2014 Oct; 21(11):3541-7. PubMed ID: 24833102 [TBL] [Abstract][Full Text] [Related]
6. Atorvastatin administration is associated with dose-related changes in IGF bioavailability. Narayanan RP; Gittins M; Siddals KW; Oliver RL; Hudson JE; White A; Durrington P; Davies RR; Rutter MK; Gibson JM Eur J Endocrinol; 2013 Apr; 168(4):543-8. PubMed ID: 23333902 [TBL] [Abstract][Full Text] [Related]
7. Postnatally elevated levels of insulin-like growth factor (IGF)-II fail to rescue the dwarfism of IGF-I-deficient mice except kidney weight. Moerth C; Schneider MR; Renner-Mueller I; Blutke A; Elmlinger MW; Erben RG; Camacho-Hübner C; Hoeflich A; Wolf E Endocrinology; 2007 Jan; 148(1):441-51. PubMed ID: 17008389 [TBL] [Abstract][Full Text] [Related]
8. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. San Millán JL; Cortón M; Villuendas G; Sancho J; Peral B; Escobar-Morreale HF J Clin Endocrinol Metab; 2004 Jun; 89(6):2640-6. PubMed ID: 15181035 [TBL] [Abstract][Full Text] [Related]
9. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance. Højlund K Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125 [TBL] [Abstract][Full Text] [Related]
10. Expression of genes encoding IGF1, IGF2, and IGFBPs in blood of obese adolescents with insulin resistance. Minchenko DO; Tsymbal DO; Davydov VV; Minchenko OH Endocr Regul; 2019 Jan; 53(1):34-45. PubMed ID: 31517621 [TBL] [Abstract][Full Text] [Related]
11. Heparin-binding mechanism of the IGF2/IGF-binding protein 2 complex. Lund J; Søndergaard MT; Conover CA; Overgaard MT J Mol Endocrinol; 2014 Jun; 52(3):345-55. PubMed ID: 24604839 [TBL] [Abstract][Full Text] [Related]
13. Prednisolone reduces the ability of serum to activate the IGF1 receptor in vitro without affecting circulating total or free IGF1. Frystyk J; Schou AJ; Heuck C; Vorum H; Lyngholm M; Flyvbjerg A; Wolthers OD Eur J Endocrinol; 2013 Jan; 168(1):1-8. PubMed ID: 23038624 [TBL] [Abstract][Full Text] [Related]
14. Insulin growth factor adjustment in preimplantation rabbit blastocysts and uterine tissues in response to maternal type 1 diabetes. Thieme R; Schindler M; Ramin N; Fischer S; Mühleck B; Fischer B; Navarrete Santos A Mol Cell Endocrinol; 2012 Jul; 358(1):96-103. PubMed ID: 22465205 [TBL] [Abstract][Full Text] [Related]
15. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk. Terry KL; Tworoger SS; Gates MA; Cramer DW; Hankinson SE Carcinogenesis; 2009 Dec; 30(12):2042-6. PubMed ID: 19858071 [TBL] [Abstract][Full Text] [Related]
16. Elevated insulin-like growth factor 2 expression may contribute to the hypermuscular phenotype of myostatin null mice. Clark DL; Clark DI; Hogan EK; Kroscher KA; Dilger AC Growth Horm IGF Res; 2015 Oct; 25(5):207-18. PubMed ID: 26198127 [TBL] [Abstract][Full Text] [Related]
17. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life. Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659 [TBL] [Abstract][Full Text] [Related]